INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It does this by facilitating collaboration between the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations).
INNOVATIVE MEDICINES INITIATIVE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Berchem, Brussels Hoofdstedelijk Gewest, Belgium
Country:
Belgium
Website Url:
http://www.imi.europa.eu
Total Employee:
1001+
Status:
Active
Contact:
+32 (0)2 221 81 81
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Nginx Euro PHP YouTube PHP 7 COVID-19 Mobile Optimized FLoC Opt-Out
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-15 | Exvastat | Innovative Medicines Initiative investment in Grant - Exvastat | 3.6 M EUR |
| 2019-01-01 | MetaHeps | Innovative Medicines Initiative investment in Grant - MetaHeps | N/A |
Official Site Inspections
http://www.imi.europa.eu
- Host name: 20.229.98.13
- IP address: 20.229.98.13
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
